Clinical Trial Update: Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tezacitabine with or without 5-fluorouracil in advanced esophageal and gastric cancers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Tezacitabine

Snippet

Sponsor: Chiron Corporation | Conditions: Esophageal Neoplasms, Stomach Neoplasms | Phase 2 | Status: COMPLETED